Skip to main content

Table 1 Results of clinical performance evaluation of CHI3L1 kit

From: Development of a chitosanase 3-like protein 1 assay kit and study of its application in patients with hepatocellular carcinoma

Minimum Detection Limit

Test 1

Test 2

Test 3

M

73695.70

72121.95

67874.05

SD

3564.94

4028.29

5985.90

M + 2SD

80825.57

80178.53

79845.85

LOD(ng/mL)

1.50

1.44

1.39

Accuracy

Concentration(ng/mL)

Average(ng/mL)

Bias(%)

 

3.00

3.01

5%

 

54.00

54.38

−2%

Precision

Average(ng/mL)

Fitted Concentration CV

Deviation of fitted concentration

 

3.10

4.2%

3%

 

56.01

2.4%

4%

Acceleration Stability

Bias

Time

Test 1

Test 2

Test 3

1 Day

2%

4%

5%

2%

−1%

2%

3 Day

−3%

3%

6%

1%

−1%

2%

6 Day

−5%

3%

6%

1%

−3%

3%

10 Day

2%

4%

−5%

3%

2%

−2%

Real-time Stability

CV value

Month

S2

S4

S6

3

5.91%

2.10%

5.41%

6

7.67%

3.92%

7.70%

9

7.53%

2.36%

7.01%

12

5.61%

1.38%

5.88%